About Daniel Macaya
Daniel Macaya is a director at Lytica Therapeutics.
Daniel Macaya first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Macaya in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Macaya works with at each company, as listed on that company's latest Form D.
Lytica Therapeutics, Inc. · Form D, Apr 11, 2025